MoonLake Immunotherapeutics
MLTX18.7105.89% ( -1.170 )
MoonLake Immunotherapeutics (MLTX)
MoonLake Immunotherapeutics, a clinical-stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseases. It develops Sonel...
- Open
- 19.650
- High
- 19.650
- Low
- 18.670
- Prev. Close
- 19.880
- Volume
- 1.05M
- Turnover
- 19.95M
- Avg Price
- 18.970
- Bid/Ask Ratio
- --
- Amplitude
- 4.93%
- 52wk High
- 62.750
- Volume Ratio
- 1.15
- Turnover Ratio
- 2.14%
MoonLake Immunotherapeutics Analyst Rating
View MoreForecast & Rating
Jul 27, 2026Price forecast
$28.0049.65%
Forecast & RatingBuy
15analysts
- Strong buy66.67%
- Buy6.67%
- Hold13.33%
- Sell13.33%
- Strong sell0.00%
News
- Global Report · 23 hours ago
The Disaggregation of the Market: Layers of Abstraction Across 10 Niche Equities
- PUBT · Jul 23 at 03:07 PM
MoonLake Immunotherapeutics CSO Kristian Reich disposes of $1 million in common shares
- PUBT · Jul 21 at 05:14 PM
MoonLake Immunotherapeutics CSO Kristian Reich sells 43,700 shares for $877,933
- PUBT · Jul 20 at 05:08 AM
MoonLake Immunotherapeutics CSO Kristian Reich sells 16,105 shares for $322,261.05
- PUBT · Jul 13 at 03:10 PM
MoonLake CEO Jorge Santos da Silva sells $2.05 million of common shares
- PUBT · Jul 2 at 03:11 PM
MoonLake CEO Jorge Santos da Silva sells 47,775 shares for $956,918.25
